НЕЙРОЭНДОКРИНОЛОГИЯ И АУТОИММУНИТЕТ -СОВРЕМЕННЫЕ АСПЕКТЫ

1. <div><p>Bijlsma J.W.J, Straub R.H., Masi A.T. et al. Neuroendocrine immune mechanisms in rheumatic diseases. Trends Immunol 2002;23:59-61.</p><p>Алекберова З.С., Фоломеев М.Ю. Половой диморфизм при ревматических заболеваниях. Ревматология 1985;2:58-61.</p><p>Lahita R.G. Gender and age in lupus. In: Lahita R.G. (ed.). Systemic lupus erythe-matosus, ed. 3. San Diego, Academic Press, 1999; p. 129-44.</p><p>Lockshin M.D. Sex differences in autoimmune disease. Lupus 2006;15:753-6.</p><p>Фоломеев М.Ю. Системная красная волчанка у мужчин: Автореф. дис. … канд. мед. наук. М., 1984.</p><p>Прокаева Т.Б. Ревматоидный артрит у мужчин (клиническая характеристика и особенности гормонального статуса): Автореф. дис. … канд. мед. наук. М., 1991.</p><p>Lahita R.G. Sex hormones and systemic lupus erythematosus. Rheum Dis Clin North Am 2000;26(4):951-68.</p><p>McMurray R.W., May W. Sex hormones and systemic lupus erythematosus. Arthritis Rheum 2003;48(8):2100-10.</p><p>Buyon J.P., Wallace D.J. The use of exogenous estrogens, endocrine system and urogenital tract. In: Dubois' Lupus erythematosus. Philadelphia, 2002; p. 821-41.</p><p>Steinberg A.D., Steinberg B.J. Lupus disease activity associated with menstrual cycle. J Rheumatol 1985;12(4):816-7.</p><p>Алекберова З.С., Карабаева А.С., Кошелева Н.М. СКВ: начало у лиц в возрасте старше 45 лет. Клин геронтол 2002;8(3):16-21.</p><p>Mok C.C., Lau C.S., Ho C.T.K. Do flares of systemic lupus erythematosus decline after menopause? Scand J Rheumatol 1999;28:357-62.</p><p>Costenbader K.H., Manson J.E. Do female hormones affect the onset or severity of rheumatoid arthritis? Arthritis Rheum 2008;59(3):299-301.</p><p>Cutolo M., Calva A. Sex steroids and immunity. In: Robert Ader's. Psychoneuroimmunology. Academic press, 2007;1: p. 207-16.</p><p>Hench P.S., Slocumb C.H., Polley H.F. et al. Effect of cortisone and pituitary adrenocorticotropic hormone on rheumatic diseases. J Am Med Assoc 1950;40:1327-35.</p><p>Bland J.H., Eddy W.M. Hemiplegia and rheumatoid hemiarthritis. Arthritis Rheum 1968;11:72-80.</p><p>Sternberg E.M. Neuroendocrine regulation of autoimmune/inflammatory diseases. J Endocrinol 2001;169:429-35.</p><p>Bijlsma J.W., Straub R.H., Masi A.T. et al. Neuroendocrine immune mechanisms in rheumatic diseases. Trends Immunol 2002;23:59-61.</p><p>Schmidt M., Weidler C., Naumann H. et al. Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes - androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5alpha-reduced androgens. Athritis Res Ther 2005;7:R938-R948.</p><p>Vacchio M.S., Ashwell J.D. Thymus-derived glucocorticoids regulate antigen-specific positive selection. J Exper Med 1997;185:2033-8.</p><p>Miller L.E., Justen H.P., Scholmerich J. The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J 2000;14:2097-107.</p><p>Labrie F. Intracrinology. Mol Cell Endocrinol 1991;78:113-8.</p><p>Labrie F., Luu-The V., Lin S.X. Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease. J Mol Endocrinol 2000;25:1-16.</p><p>Martel C., Rheaume E., Takahashi M. et al. Distribution of 17 beta-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues. J Steroid Biochem Mol Biol 1992;41:597-603.</p><p>Levine J.D., Clark R., Devor M. et al. Intraneuronal substance P contributes to the severity of experimental arthritis. Science 1984;226:547-9.</p><p>Cutolo M., Straub R.H., Bijlsma W.J. Neuroendocrine-immune interactions in synovitis. Nature Clinical Pract Rheumatol</p><p>Cutolo M., Accardo S., Villaggio B. et al. Androgen and estrogen receptors are present in primary cultures of human synovial macrophages. J Clin Endocrinol Metab 1996;81:820-7.</p><p>Le Bail J., Pouget C., Fagnere C. et al. Aromatase in synovial cells from post-menopausal women. Steroids 2001;66:749-57.</p><p>Dhabnar F.S., McEwen B.S. Bidirectional effects of stress and glucocorticoid hormones on immune function: possible explanations for paradoxical observations. In: Robert Ader's. Psychoneuroimmunology. Academic Press, 2001; p. 301-38.</p><p>Straub R.H., Grifka J., Scholmerich J. et al. Neurotransmitters of the sympathetic nerve terminal are poweful chemoattractants for monocytes. J Leukoc Biol 2000;67:553-8.</p><p>Elenkov I.J., Wilder R.L., Chrousos G.P. et al. The sympathetic nervous system - an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000;52:595-638.</p><p>Miller L.E., Grifka J., Scholmerich J. et al. Norepinephrine from synovial tyrosine hydroxylase positive cells is a strong indicator of synovial inflammation in rheumatoid arthritis. J Rheumatol 2002;29:427-35.</p><p>Straub R.H., Gunzler C., Miller L.E. et al. Anti-inflammatory cooperativity of corticosteroids and norepinephrine in rheumatoid arthritis synovial tissue in vivo and in vitro. FASEB J 2002;16:993-1005.</p><p>Elenkov I.J., Chrousos G.P. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol Metab 1999;10:359-68.</p><p>Calcagni E., Elenkov I.J. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann N Y Acad Sci 2006;1069:62-76.</p><p>Harle P., Straaub R.H., Wiest R. et al. Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response system. Ann Rheum Dis 2006;56:51-6.</p><p>Eijsbouts A.M., van den Hoogen F.H., Laan R.F. et al. Hypothalamic-pituitary adrenal axis activity in patients with rheumatoid arthritis. Clin Exp Rheumatol 2005;23(5):658-64.</p><p>Cutolo M., Montecucco C.M., Cavagna L. et al. Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis. Ann Rheum Dis 2006;65(11):1438-43.</p><p>van Rossum E.F., Lamberts S.W. Glucocorticoid resistance syndrome: A diagnostic and therapeutic approach. Best Pract Res Clin Endocrinol Metab 2006;20(4):611-26.</p><p>Harbuz M.S., Chover-Gonzalez A.J., Jessop D.S. Hypothalamic-pituitary adrenal axis and chronic immune activation. Ann N Y Acad Sci 2003;992:99-106.</p><p>Cutolo M., Straub R.H. Stress as a risk factor in the pathogenesis of rheumatoid arthritis. Neuroimmunomodulation 2006;13(5-6):277-82.</p><p>Geenen R., van Middendorp H.V., Bijlsma W.J. The impact of stressors on health status and hypothalamic-pituitary adrenal axis and autonomic nervous system responsiveness in rheumatoid arthritis. In: Basic and clinical aspects of neuroendocrine immunology in rheumatic diseases. Ann N Y Acad Sci 2006;1069:77-97.</p><p>Bijlsma J.W., Straub R.H., Masi A.T. et al. Neuroendocrine immune mechanisms in rheumatic diseases. Trend Immunol 2002;23:59-66.</p><p>Van V.R., McGuire J.L. Estrogen, progesteron, and testosterone: Can they be used to treat autoimmune diseases? Cleve Clin J Med 1994;61:276-84.</p><p>Cutolo M., Villaggio B., Craviotto C. et al. Sex hormones and rheumatoid arthritis. Autoimmun Rev 2002;1:284-9.</p><p>Lahita R.G., Bradlow H.L., Ginzler E. et al. Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum 1987;30:241-8.</p><p>Macdiarmid F., Wang D., Duncan L.G. Stimulation of aromatase activity in breast fibroblasts by tumor necrosis factor alfa. Mol Cell Endocrinol 1994;106:17-21.</p><p>Castagnetta L., Cutolo M., Granata O. et al. Endocrine end-points in rheumatoid arthritis. Ann N Y Acad Sci 1999;876:180-92.</p><p>Folomeev M.Y., Dougados M., Beaune J. et al. Plasma sex hormones and aromatase activity in tissues of patients with systemic lupus erythematosus. Lupus 1992;1(3):191-5.</p><p>Lahita R.G. Sex steroids and SLE: Metabolism of androgens to estrogens [editorial]. Lupus 1992;1:125-7.</p><p>Lahita R.G., Bradlow H.L., Kunkel H.G. et al. Increased 16-hydroxylation of estradiol in systemic lupus erythematosus. J Clin Endocrinol Metab 1981;53:174-8.</p><p>Shabanova S.S., Ananieva L.P., Alekberova Z.S., Guzov I.I. Ovarian function and disease activity in patients with systemic lupus erythematosus. Clin Exp Rheum 2008;26(3):436-41.</p><p>Munoz J.A., Gil A., Lopez-Dupla J.M. et al. Sex hormones in chronic systemic lupus erythematosus. Ann Med Interne 1994;145(7):459-63.</p><p>Bucala R., Lahita R.G., Fishman J. et al. Anti-oestrogen antibodies in users of contraceptives and patiens with systemic lupus erythematosus. Clin Exp Immunol 1987;67(1):167-75.</p><p>Castagnetta L., Carruba G., Granata O. et al. Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis. J Rheumatol 2003;30:2597-605.</p><p>Cutolo M., Sulli A., Seriolo B. et al. Estrogens, the immune response and autoimmunity. Clin Exp Rheum 1995;13:217-26.</p><p>Cutolo M. Estrogen metabolites: increasing evidence for their role in rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 2004;31:419-21.</p><p>Kramer P.R., Kramer S.F., Guan G. 17 beta-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages. Arthritis Rheum 2004;50:1967-75.</p><p>Honma S., Shimodaira K., Shimuzu Y. et al. The influence of inflammatory cytokines on estrogen production and cell proliferation in human breast cancer cells. Endocr J 2002;49:371-7.</p><p>Cutolo M., Lahita R. Estrogens and arthritis. Rheum Dis Clin North Am 2005;31:19-27.</p><p>Cutolo M., Capellino S., Montagna P. et al. Hormone modulation of cell growth and apoptosis of the human monocytic/macrophage cell line. Arthritis Res Ther 2005;7:1124-33.</p><p>Herrmann M., Winkler T., Gaipl U. Etiopathogenesis of systemic lupus erythematosus. Int Arch Allergy Immunol 2000;123:28-35.</p><p>Funauchi M., Ikoma S., Enomoto H. Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus. Scand J Rheumatol 1998;27:219-24.</p><p>Llorente L., Richaud-Patin Y., Wijdenes J. et al. Spontaneous production of IL-10 by B-lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytocine Netw 1993;4:421-7.</p><p>Olsen N.J., Viselli S.M., Pan J. et al. Androgens accelerate thymocyte apoptosis. Endocrinology 1998;139:748-52.</p><p>Hakuno N., Koji T., Yano T. et al. Fas/APO-1/CD95 system as a mediator of granulosa cell apoptosis in ovarian follicle atresia. Endocrinology 1996;137:1938-48.</p><p>Weidler C., Harle P., Schedel J. et al. Patients with rheumatoid arthritis and systemic lupus erythematosus have increased renal excretion of mitogenic estrogens in relation to endogenous antiestrogens. J Rheumatol 2004;31:489-95.</p><p>Miyaura C., Onoe Y., Inada M. et al. Increased B lymphopoiesis by IL 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. Proc Natl Acad Sci USA 1997;94:9360-5.</p><p>Cohen-Solal J.F.G., Jeganathan V., Hill L. et al. Hormonal regulation of B-cells function and systemic lupus erythematosus. Lupus 2008;17:528-32.</p><p>Bynoe M.S., Spatz L., Diamond B. Characterization of anti-DNA B cells that escape negative selection. Eur J Immunol 1999;29:1304-13.</p><p>Kanda N., Tsuchida T., Tamaki K. Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:1703-11.</p><p>Lahita R.G., Bradlow H.L., Ginzler E. Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum 1987;30:241-8.</p><p>Van Vollenhoven R.F. Dehydroepiandrosterone in systemic lupus erythematosus. Rheum Dis Clin North Am 2000;26(2):349-62.</p><p>Насонов Е.Л., Клюквина Н.Г., Масенко В.П., Алекберова З.С. Пролактин при ревматических заболеваниях. Клин ревматол 1997;2:23-38.</p><p>Lahat V. et al. Differential effects of prolactin upon activation and differentiation of human B lymphocytes. J Neuroimmunol 1993;47:35-40.</p><p>Spangelo B.L. et al. Stimulation of in vivo antibody production and cocanavalin-A-induced mouse spleen cell mitogenesis by prolactin. Immunopharmacol 1987;14:11-20.</p><p>Jimena P., Aguirre M.A., Lopez-Curbelo A. et al. Prolactin levels in patients with systemic lupus erythematosus: a case controlled study. Lupus 1998;7:383-6.</p><p>Huang C.-M., Chou C.-T. Hyperprolactinemia in systemic lupus erythematosus. Clin Med J 1997;59:37-41.</p><p>Blanco Favela F., Quintal-Alvarez G., Leanos-Miranda A. Association between prolactin and disease activity in systemic lupus erythematosus. Influence of statistical power. J Rheumatol 1999;26:55-9.</p><p>Buskila D., Lorber M., Neumann L. et al. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. J Rheumatol 1996;23:629-32.</p><p>Miranda J.M., Prieto R.E., Paniagua R. et al. Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis. Lupus 1998;7:387-91.</p><p>McMurray R.W., Weidensaul D., Allen S.H. et al. Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. J Rheumatol 1995;22:2084-91.</p><p>Van V.R., McGuire J.L. Estrogen, progesteron, and testosterone: Can they be used to treat autoimmune diseases? Cleve Clin J Med 1994;61:276-84.</p><p>Arnalich F., Benito U.S., Gonzales G.P. et al. Inadequate production of the progesterone in women with systemic lupus erythematosus. Br J Rheumatol 1992;31:247-51.</p><p>Straub R.H., Buttgereit F., Cutolo M. Benefit of pregnancy in inflammatory arthritis. Ann Rheum Dis 2005;64:801-3.</p><p>Munoz-Valle J.F., Vazquez-Del Mercado M., Garcia-Iglesias T. et al. Th-1/Th-2 cytokine profile, metalloprotease-9 activity and hormonal status in pregnant rheumatoid arthritis and systemic lupus erythematosus patients. Clin Exp Immunol 2003;131:377-84.</p><p>Doria A., Ghirardello A., Punzi L. et al. Pregnancy, cytokines and disease activity in systemic lupus erythematosus. Arthritis Rheum 2004;15:989-95.</p><p>Кошелева Н.М., Хузмиева С.И., Алекберова З.С. Системная красная волчанка и беременность. II. Влияние системной красной волчанки на исходы беременности. Науч-практ ревматол 2006;2:52-9.</p><p>Kvien T.K., Uhlig T., Odegard S. et al. Epidemiological aspects of the sex ratio. Ann N Y Acad Sci 2006;1069:212-22.</p><p>Cutolo M., Sulli A., Capellino S. et al. Anti-TNF and sex hormones. Ann N Y Acad Sci 2006;1069:391-400.</p></div><br />